1)Thymus[英]['θaim?s][美]['θa?m?s]胸腺组织
1.ObjectWith techniques of 2-DE (Two-dimensional gel electrophoresis), the thesis analyzes the proteome of myasthenia gravis hyperplastic thymus tissue and screens the MG related proteins, which then identified by matrix assisted laser desorption ionization time of flight mass spectrometry (MALDI -TOF-MS).目的 初步建立MG胸腺组织蛋白质组学研究方法，获得双向电泳凝胶图谱，筛选出胸腺组织重症肌无力相关蛋白，并对其作出鉴定。
英文短句/例句
1.The Mechanisms and Effects of γ-irradiation on the Thymus;胸腺组织辐射损伤效应和机理的研究
2.Study on the Relationship between the Expression of Fas and the Genesis of Myasthenia Gravis in the Latero-thymoma Thymus Tissue胸腺瘤旁胸腺组织Fas表达与重症肌无力发生的相关性研究
3.Identification of the Related Proteins in Myasthenia Gravis Hyperplastic Thymus Tissues;重症肌无力胸腺组织相关蛋白鉴定研究
4.Expression of Aspartylglucosaminidase and Sorting Nexins17 at Transcriptional Levels in Thymic Tissue of MG;重症肌无力患者胸腺组织中AGA和SNX17基因mRNA的表达
5.Effects of exercises training on thymic tissue's apoptosis of rats after long-term stop trained运动训练长期停训对大鼠胸腺组织细胞凋亡的影响
6.The expression of karyopherin alpha-5 in the thymus tissue of the patients with myasthenia gravis.重症肌无力患者胸腺组织核胞浆转运蛋白α-5的表达研究
7.Expression of Costimulatory Molecule B7-H1 in Thymic Tissue in Patients of Myasthenia Gravis共刺激分子B7-H1在重症肌无力患者胸腺组织中的表达
8.Effects of mesenchymal stem cells on thymus tissue injury induced by ionizing radiation in mice骨髓间充质干细胞在电离辐射诱发的小鼠胸腺组织损伤中的作用
9.Effects of Order Supplement and Simply SupplementMethod on Glucocorticoid Receptor in BrainCytosol and Glucocorticoid Receptor in Thymusof Rat during Chronic Exercise Stress;序贯法和单纯进补法对慢性运动应激大鼠脑组织和胸腺组织糖皮质激素受体的影响
10.thymic alymphoplasia胸腺淋巴组织发育不全
11.WHO Histologic Classification of Thymoma and its Relationship with Thymoma Diagnosis and Treatment胸腺瘤WHO组织学分型与胸腺瘤诊治的关系
12.The Clinical Study and Pathology Classification of 68 Cases Thymoma;68例胸腺瘤组织学分类与临床分析
13.The Anatomical and Histological Observation of Several Congenital Malformation Fetus Thymus;几种先天畸形胎儿胸腺的解剖及组织观察
14.MRI Appearances of Thymoma and Correlation Study with Histo-pathology胸腺瘤MRI表现与其组织病理学分型的相关研究
15.Lipid Peroxidation in Liver and Brain of Adult Thymectonmized Rats and Aged Rats成年去胸腺大鼠及老年大鼠肝、脑组织脂质过氧化作用的研究
16.Repartion and Immunohistochemical Study of Monoclonal Antibodies to Duck Thymocyte;抗鸭胸腺细胞单克隆抗体的制备及其免疫组织化学研究
17.Tobacco transformation of thymosin alpha 1 gene byAgrobacterium-mediated method and study of tissueculture of notholirion bu;农杆菌介导的胸腺素α1基因转化烟草和太白米组织培养研究
18.Experimental Study on Intrathymic Inoculation of Allogeneic Antigen Induces Organization Allograft Immunotolerance in Mice;胸腺内注射异基因抗原诱导鼠异体组织移植免疫耐受的实验研究
相关短句/例句
thymus tissue胸腺组织
1.Clinical and Pathologic Study on the Expression of HBsAg in the Thymus Tissues of the Died Fetusion;死胎胸腺组织中HBsAg检测的临床和病理研究
2.Purpose: To discuss the anatomical and histological structure character of congenital malformation fetal thymus and the relationships betwween the different abnormality and the development of thymu Method: To dissect and observe the thymic configuration,and generally to draw materials,stained by hematoxylin-eosine,then to study the thymus tissue slices under the light microscope.方法:解剖观察胸腺的形态,常规取材,苏木精———伊红染色,光学显微镜下观察胸腺组织。
3)Thymic Tissue胸腺组织
1.Expression of Costimulatory Molecule B7-H1 in Thymic Tissue in Patients of Myasthenia Gravis共刺激分子B7-H1在重症肌无力患者胸腺组织中的表达
2.METHODS: Total RNA was extracted and purified from thymic tissues of 6 MG cases and 6 normal cases.目的:筛查胸腺组织重症肌无力(MG)相关基因,探讨MG发生机制。
4)accessory thymic tissue副胸腺组织
5)histological development of thymus胸腺发育组织学
6)World Health Organization schemaWHO胸腺瘤组织分型标准
1.World Health Organization schema for thymoma classification:a retrospective analysis of 93 cases;方法按新的WHO胸腺瘤组织分型标准对我科手术治疗的93例胸腺瘤进行了回顾性分析,总结本组病例的组织分型、Masaoka分期及预后。
延伸阅读
胸腺多肽,胸腺素F5,胸腺素,胸腺素注射液药物名称：胸腺肽注射液英文名：Thymopetidum Injection别名：胸腺多肽,胸腺素F5,胸腺素,胸腺素注射液、胸腺因子注射液、胸腺因子D注射液。性状：本品为无色或微黄色澄明液体。药理作用： 促使骨髓产生的干细胞转变为T细胞，从而增强细胞免疫功能。 从健康乳牛胸腺中提取制得的多肽类细胞免疫调节剂。可作用于T淋巴细胞分化的各个阶段，有调节和增强人体免疫功能的作用，可提高机体的防病抗病能力，缩短感染性疾病的治疗周期。用于原发或继发性免疫缺陷病或免疫功能失调引起的各种疾病、自身免疫性疾病以及病毒或细菌性感染和肿瘤的辅助治疗。适应症： 用于免疫缺陷病、恶性肿瘤及病毒性疾病。 用于治疗各种原发性或继发性T细胞缺陷病，某些自身免疫性疾病，各种细胞免疫功能低下的疾病及肿瘤的辅助治疗.用量用法： 肌注：每次2-10mg，每日或隔日1次。对于胸腺发育不全症患者应做替代治疗，每日1mg/kg，病情好转后改为维持量每周1mg/kg。 静脉滴注：一次20～80mg，溶于500ml，0.9%氯化钠注射液或5%葡萄糖注射液，一日1次或遵医嘱。注意事项：1.对于过敏体质者，注射前或治疗终止后再用药时需做皮内敏感试验（配成25μg/ml的溶液，皮内注射0.1ml），阳性反应者禁用。2.本品如出现混浊或絮状沉淀物等异常变化，禁忌使用。3. 有发热、头晕、皮疹等。规格： 注射剂：2mg/2ml；5mg/2ml。2ml:5mg;2ml：20mg类别：免疫调节剂
